Showing 3351-3360 of 5698 results for "".
- With EyeCare Partners Deal, Swiss Firm Sees a Base for ‘Organic Growth, Expansion and Consolidation’ of U.S. Vision Markethttps://modernod.com/news/with-eyecare-partners-deal-swiss-firm-sees-a-base-for-organic-growth-expansion-and-consolidation-of-u-s-vision-market/2477176/In the second major acquisition of an eyecare practice management group this year, the Switzerland-based Partners Group announced Monday morning that it has agreed to make a significant investment in EyeCare Partners LLC (ECP). FFL Partners announced separately that it was selling the stake it ha
- UK Regulator Unconditionally Clears Roche’s Purchase of Spark Therapeuticshttps://modernod.com/news/uk-regulator-unconditionally-clears-roches-purchase-of-spark-therapeutics/2477170/The UK Competition and Markets Authority (CMA) announced Monday the clearance of Roche’s proposed purchase of Spark Therapeutics after concluding that the deal would not negatively affect competition for haemophilia A treatments. The Swiss drugmaker noted that the offer period under the tra
- ImprimisRx’s FDA-Registered Outsourcing Facility Issued California Licensehttps://modernod.com/news/imprimisrxs-fda-registered-outsourcing-facility-issued-california-license/2477158/ImprimisRx announced that on December 9, 2019, its FDA-registered 503B outsourcing facility received a non-resident operating license and has now begun shipping into California. This license allows California-based ophthalmologists, optometrists, surgery centers and hospitals to order and stock I
- Quick Eye Test May Flag Unrecognized Brain Injuryhttps://modernod.com/news/quick-eye-test-may-flag-unrecognized-brain-injury/2477145/A quick, noninvasive, handheld device that detects changes in pupil size may offer rapid assessment of potential brain injury in young athletes who have sustained a high-impact hit to the head but who exhibit no obvious signs of brain injury, according to a
- NORA and Pink Concussions Offer New Educational Resource on Women and Concussionshttps://modernod.com/news/nora-and-pink-concussions-offer-new-educational-resource-on-women-and-concussions/2477132/There is little known about the specific effects of traumatic brain injuries (TBI), such as concussions, on women, mainly because the majority of published studies on the subject have focused more on men. A growing body of evidence suggests, however, that females have a higher rate of concussions
- GN Corporation: Vision Restored with Corneal Cell Transplant Using a Nano Sheet Techniquehttps://modernod.com/news/gn-corporation-vision-restored-with-corneal-cell-transplant-using-a-nano-sheet-technique/2477121/A novel cell transplantation method to treat corneal endothelial diseases such as bullous keratopathy using a nano-composite gel sheet developed by Japanese scientists was granted Indian patent to GN Corporation (GNC), Japan, according to a company news release. This method was earlier granted a
- EnChroma Makes New Indoor Color Blind Glasses Available to the Publichttps://modernod.com/news/enchroma-makes-new-indoor-color-blind-glasses-available-to-the-public/2477109/EnChroma announced the launch of EnChroma Cx1 Indoor DT, an improved indoor lens designed specifically for Deutan-type color blindness. The glasses are now available for purchase online at
- CovalentCareers Releases 2019 Optometrist Reporthttps://modernod.com/news/covalentcareers-releases-2019-optometrist-report/2477100/Career development company CovalentCareers has released its 2019 Optometrist Report, which is now available for free for eyecare professionals. Based on data collected from 1,181 optometrists, optometry studen
- Iveric bio Initiating Second Pivotal Clinical Trial of Zimura in GA Secondary to Dry AMDhttps://modernod.com/news/iveric-bio-initiating-second-pivotal-clinical-trial-of-zimura-in-ga-with-1q-2020-targeted-for-first-patient-enrolled/2477090/Iveric bio provided further clinical details and its development strategy for Zimura (avacincaptad pegol), a novel complement C5 inhibitor, for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). Based on the study design and the robustness of the rec
- Armenian EyeCare Project Surpasses Milestone of 10,000 Patients Screened Using Artificial Intelligence Eye Screening Technologyhttps://modernod.com/news/armenian-eyecare-project-surpasses-milestone-of-10000-patients-screened-using-artificial-intelligence-eye-screening-technology/2477088/On this World Diabetes Day, the Armenian EyeCare Project (AECP), a nonprofit organization dedicated to eliminating preventable blindness in Armenia, announced that it has surpassed the milestone of screening 10,000 patients for diabetic retinopathy (DR) throughout Armenia utilizing the state-of-a